Related references
Note: Only part of the references are listed.Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123
Laurent Gauthier et al.
NATURE BIOTECHNOLOGY (2023)
Materials for Cell Surface Engineering
Kolade Adebowale et al.
ADVANCED MATERIALS (2023)
A backpack-based myeloid cell therapy for multiple sclerosis
Neha Kapate et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy
Melissa M. Berrien-Elliott et al.
BLOOD (2022)
Manipulating Nanoparticle Aggregates Regulates Receptor-Ligand Binding in Macrophages
Yuri Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)
Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy
Wanze Zhang et al.
MOLECULAR IMMUNOLOGY (2022)
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges
Alessandro Poggi et al.
MOLECULAR THERAPY-ONCOLYTICS (2022)
Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells
Sainiteesh Maddineni et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Nina Lamers-Kok et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation
Annelies C. Wauters et al.
ACS NANO (2022)
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri et al.
FRONTIERS IN IMMUNOLOGY (2022)
Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC)
Manuela Sauter et al.
STAR PROTOCOLS (2022)
Natural killer cells in antitumour adoptive cell immunotherapy
Tamara J. Laskowski et al.
NATURE REVIEWS CANCER (2022)
A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells
Upasana Sunil Arvindam et al.
LEUKEMIA (2021)
Cell-bound nanoparticles for tissue targeting and immunotherapy: Engineering of the particle-membrane interface
Supriya Prakash et al.
CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2021)
Targeting metastatic cancer
Karuna Ganesh et al.
NATURE MEDICINE (2021)
Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology
Paula Schmidt et al.
FRONTIERS IN IMMUNOLOGY (2021)
Cell therapies in the clinic
Lily Li-Wen Wang et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)
Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy
Kewen Lei et al.
NATURE BIOMEDICAL ENGINEERING (2021)
IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella
Qiubin Lin et al.
NATURE COMMUNICATIONS (2021)
Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments
Olivier Demaria et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2021)
Engineering the next generation of CAR-NK immunotherapies
Alexander Biederstaedt et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)
Nonviral genome engineering of natural killer cells
Gabrielle M. Robbins et al.
STEM CELL RESEARCH & THERAPY (2021)
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano et al.
CANCERS (2021)
NK Cell Therapy: A Rising Star in Cancer Treatment
Nawen Du et al.
CANCERS (2021)
From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
Hui Lu et al.
FRONTIERS IN ONCOLOGY (2021)
The Epidemiology of Lung Metastases
Hanbo Chen et al.
FRONTIERS IN MEDICINE (2021)
Preparation and culture of bone marrow-derived macrophages from mice for functional analysis
Gotaro Toda et al.
STAR PROTOCOLS (2021)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence
Sean J. Judge et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Predicting the Miscibility and Rigidity of Poly(lactic-co-glycolic acid)/Polyethylene Glycol Blends via Molecular Dynamics Simulations
Martina Pannuzzo et al.
MACROMOLECULES (2020)
Cellular backpacks for macrophage immunotherapy
C. Wyatt Shields et al.
SCIENCE ADVANCES (2020)
Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers
Sareetha Kailayangiri et al.
CANCERS (2020)
Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy
Loris Zamai et al.
CELLS (2020)
NKp30-A prospective target for new cancer immunotherapy strategies
Pedro F. Pinheiro et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy
Kin Man Au et al.
SCIENCE ADVANCES (2020)
Mechanical Immunoengineering of T cells for Therapeutic Applications
Kewen Lei et al.
ACCOUNTS OF CHEMICAL RESEARCH (2020)
Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy
Yuqing Cao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Cytokines in the Treatment of Cancer
Kevin C. Conlon et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)
Mechanisms of resistance to CAR T cell therapy
Nirali N. Shah et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity
Laurent Gauthier et al.
CELL (2019)
The Natural Cytotoxicity Receptors in Health and Disease
Alexander David Barrow et al.
FRONTIERS IN IMMUNOLOGY (2019)
Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion
Andrew J. Freeman et al.
CELL REPORTS (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Driving CARs on the uneven road of antigen heterogeneity in solid tumors
Nan Chen et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells
Alexander S. Cheung et al.
NATURE BIOTECHNOLOGY (2018)
Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
Li Tang et al.
NATURE BIOTECHNOLOGY (2018)
CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells
Juyoung Kim et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2018)
Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid
Claudia Lennicke et al.
ONCOIMMUNOLOGY (2017)
Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells
Rachel S. Riley et al.
SMALL (2017)
Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity
Purnima Bhat et al.
CELL DEATH & DISEASE (2017)
IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function
Daniel A. Vallera et al.
CLINICAL CANCER RESEARCH (2016)
Tuning Cellular Uptake of Molecular Probes by Rational Design of Their Assembly into Supramolecular Nanoprobes
Lye Lin Lock et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo
Erik Wennerberg et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
Michelle K. Gleason et al.
BLOOD (2014)
IFN-γ Primes Macrophage Activation by Increasing Phosphatase and Tensin Homolog via Downregulation of miR-3473b
Cong Wu et al.
JOURNAL OF IMMUNOLOGY (2014)
Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy
Varun Kumar et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity
Konrad Krzewski et al.
BLOOD (2013)
Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1
Ruipeng Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Cell-Based Drug Delivery Devices Using Phagocytosis-Resistant Backpacks
Nishit Doshi et al.
ADVANCED MATERIALS (2011)
A rapid method for assessment of natural killer cell function after multiple receptor crosslinking
Z. B. Al-Hubeshy et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2011)
IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice
Kazuyoshi Takeda et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Tumor Necrosis Factor-a Signaling in Macrophages
Narayanan Parameswaran et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)
Nanoparticle-Mediated IgE-Receptor Aggregation and Signaling in RBL Mast Cells
Yu-Fen Huang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
IFN-γ arms human dendritic cells to perform multiple effector functions
Loredana Frasca et al.
JOURNAL OF IMMUNOLOGY (2008)
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
YT Bryceson et al.
BLOOD (2006)